Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1996
11/21/1996CA2219129A1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors
11/21/1996CA2219082A1 Use of dihydrotestosterone compounds for treating male sexual dysfunction
11/21/1996CA2218548A1 Xanthines and their therapeutic use
11/21/1996CA2195455A1 Use of glyceryl triacetate for treating onychomycoses
11/21/1996CA2194463A1 Terpenoidic derivatives useful as antitumor agents
11/20/1996EP0743323A1 Saccharide fraction obtainable from starch, its use as active principle in the treatment of wounds and ulcers and pharmaceutical compositions containing it
11/20/1996EP0743320A2 Acyl guanidine and amidine prodrugs
11/20/1996EP0743319A1 Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ace and nep
11/20/1996EP0743312A1 Spiroheterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
11/20/1996EP0743304A1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones
11/20/1996EP0743302A2 Sulfonamide fibrinogen receptor antagonists
11/20/1996EP0743301A2 Benzoylguanidines containing fluorine
11/20/1996EP0743300A1 15-Deoxyspergualine-related compounds, process for their preparation and their application in therapy
11/20/1996EP0743067A2 Use of urea and thiourea compounds for elimination or detoxofication of superantigens from body fluids
11/20/1996EP0743066A2 Wound-healing agent
11/20/1996EP0743065A2 Vanadium compounds for inhibiting bone loss
11/20/1996EP0743064A1 Leukotriene antagonists for use in the treatment or prevention of alzheimer's disease
11/20/1996EP0743063A1 Use of derivatives of alpha-aminomethyl-3,4-dichlorobenzyl thioacetamide for the preparation of a medicament inhibiting the recapture of dopamine and compounds for this use
11/20/1996EP0743059A2 Process for applying antibacterial oral composition to dental implant areas
11/20/1996EP0742790A1 Substituted purines and oligonucleotide cross-linking
11/20/1996EP0742789A1 Pharmaceutically active compounds and liposomes, and methods of use therof
11/20/1996EP0742717A1 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
11/20/1996EP0742716A1 Pharmaceutical composition for systemic transdermal administration containing the active agent morphine-6-glucuronide
11/20/1996EP0742715A1 Oral liquid compositions containing paroxetine resinate
11/20/1996EP0742714A1 Liquid pharmaceutical compositions comprising thyroid hormones
11/20/1996EP0742712A1 Bilayered amoxycillin tablets
11/20/1996EP0658103B1 Beads having a core coated with an antifungal and a polymer
11/20/1996EP0656783B1 Pharmaceuticals containing onconase and cisplatin, melphalan and adriamycin
11/20/1996EP0648122B1 PREVENTING TISSUE ADHESION USING $i(IN SITU) MODIFICATION OF ALGINATE
11/20/1996EP0648108B1 Prophylactic and therapeutical preparation against caries
11/20/1996EP0639191B1 Indazol-3-one-2-yl derivatives of benzopyrans
11/20/1996EP0627009B1 Macrocyclic lactones and a productive strain thereof
11/20/1996EP0618768B1 Antiseptic
11/20/1996EP0596943B1 Process for purifying pentostatin
11/20/1996EP0548208B1 Method for treating eye disorders by reducing 12(r)-hydroxyeicosatetraenoic acid and 12(r)-dihydroxyeicosatrienoic acid levels
11/20/1996EP0531529B1 Process for preparing aqueous suspension
11/20/1996EP0531415B1 Method for treating alcoholism with nalmefene
11/20/1996CN1136327A Using antisense oligonucleotides to modulate nerve growth and to reverse 'beta'/A4 amyloid-induced morphology
11/20/1996CN1136318A 16-substituted -4-aza-androstane 5-alpha-reductase isoazyne 1 inhibitors
11/20/1996CN1136317A Anthracycline disaccharides, process for their preparation, and pharmaceutical compositions containing them
11/20/1996CN1136316A Biologically active silicon compounds and their therapeutic and cosmetic applications
11/20/1996CN1136315A Method for preparing concentrated biologically active silicon compounds
11/20/1996CN1136314A Isoxazoline compounds as antiinflammatory agents
11/20/1996CN1136313A Polyazacycloalkanes as dichelants
11/20/1996CN1136312A Heterocyclic benzenesulfonylimine derivatives as inhibitors of IL-1 action
11/20/1996CN1136311A Novel benzenesulfonylimine derivatives as inhibitors of IL-1 action
11/20/1996CN1136281A Arteriosclerosis remedy
11/20/1996CN1136279A Extract from the leaves of gingko biloba
11/20/1996CN1136278A Combination of bisphosphonates and growth hormone secretagogues
11/20/1996CN1136277A Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infections
11/20/1996CN1136276A Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections
11/20/1996CN1136275A Heteroarylpiperidines, pyrrolidines and piprazines and their use as antipsychotics and analgetics
11/20/1996CN1136274A Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide
11/20/1996CN1136266A 新的饮料 New beverage
11/20/1996CN1136039A |3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy¨-pyridine, pyrimidine and benzene derivatives as alpha1-adrenoceptor antagonists
11/20/1996CN1136036A 磺酰胺衍生物 Sulfonamide derivatives
11/20/1996CN1135882A Brufen pellet
11/20/1996CN1135841A Fortified milk
11/20/1996CN1033327C Process for preparing tricyclotriazolo derivatives
11/20/1996CN1033325C Preparation of antiinflammatory hydroxamic acids and N-hydroxyureas
11/20/1996CN1033308C One-seep sublimer for extracting natural caffeine from tea
11/20/1996CA2176654A1 Use of (.alpha.-aminomethyl-3,4-dichlorobenzyl)thioacetamide derivatives for inhibiting dopamine reuptake and new compounds for this use
11/19/1996US5576450 Process for preparing taxoids
11/19/1996US5576448 N-(3-hydroxy-4-piperidinyl) (dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
11/19/1996US5576447 Process for the preparation of amidino phenyl pyrrolidine β-alanine urea analogs
11/19/1996US5576446 1-amino-2-(substituted)pyrroles and related compounds
11/19/1996US5576444 Cyclic imino derivatives, processes for preparing them and pharmaceutical compositions containing these compounds
11/19/1996US5576442 Reduction of ketone with borane in the presence of oxazaborolidine catalyst in cyclic ether solvent
11/19/1996US5576438 Lipoxygenase inhibitors; antiallergens, antiinflammatory agents
11/19/1996US5576437 7-(2-imidazolnylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists
11/19/1996US5576435 Process and intermediates for the preparation of excitatory amino acid receptor antagonists
11/19/1996US5576429 5-substituted pyrimidine nucleosides and nucleotides
11/19/1996US5576427 Compounds which replace nucleosides in an oligonucleotide to inhibit nuclease degradation of oligonucleotide
11/19/1996US5576418 Resorbable biocompatible copolymers and their use
11/19/1996US5576355 Inhibiting human t-cell leukemia/lymphoma virus
11/19/1996US5576354 Photostable cosmetic screening composition containing a UV-A screening agent and an alkyl β, β-diphenylacrylate or α-cyano-β,β-diphenylacrylate
11/19/1996US5576353 Method of treating memory disorders using R-enantiomers of N-propargyl-aminoindan compounds
11/19/1996US5576352 Method of inhibiting gastric acid secretion with aryloxypropanolamines
11/19/1996US5576351 Use of arginine as an immunostimulator
11/19/1996US5576350 Shock produced by bacteria
11/19/1996US5576349 Retionoic acid treatment of cardiac arrhythmia
11/19/1996US5576348 Treatment of metabolic dysfunction syndrome
11/19/1996US5576347 Method of treating gastric ulcers
11/19/1996US5576346 Administering a substituted chromone
11/19/1996US5576345 Method and means for inhibiting posterior capsule opacification
11/19/1996US5576344 Process for reducing the adverse taste and malodor associated with H2 -antagonists
11/19/1996US5576343 Aromatic amidine derivatives and salts thereof
11/19/1996US5576341 2-[[2-(N-isobutyl-N-methyl)amino]benzylsulfinyl]-benzimidazole as antimicrobial agent
11/19/1996US5576340 Aromatic amino-alcohol derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses
11/19/1996US5576337 Method of treating anxiety by inhibiting physiological conditions associated with an excess of neuropeptide Y
11/19/1996US5576334 Acylurea derivatives
11/19/1996US5576333 Asthma treatment
11/19/1996US5576331 Administering 2-(4-chlorobenzoylamino)-3-(2-quinolon-4-yl) propionic acid or salt
11/19/1996US5576330 Mixture of an angiogenesis inhibitor and an antitumor agent
11/19/1996US5576329 Method for treating tendon or joint inflammation with papaverine HCL
11/19/1996US5576328 Method for the secondary prevention of ischemic events
11/19/1996US5576327 Treatment of heart rhythym disorders by administration of 3-phenylsulfonyl-3, 7-diazabicyclo[3.3.1]nonane compounds
11/19/1996US5576325 Pyrrolyl-4h-pyranoquinolines
11/19/1996US5576323 Excitatory amino acid receptor antagonists
11/19/1996US5576322 Anti-ischemic 2,4-diaminoquinazolines
1 ... 6858 6859 6860 6861 6862 6863 6864 6865 6866 6867 6868 6869 6870 6871 6872 6873 6874 6875 6876 6877 6878 ... 7860